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The molecular-level cause of sleep is unknown. In 2012, we suggested
that the cause of sleep stems from cumulative effects of numerous
intracellular and extracellular protein fragments. According to the
fragment generation (FG) hypothesis, protein fragments (which are
continually produced through nonprocessive cleavages by intracel-
lular, intramembrane, and extracellular proteases) can be beneficial
but toxic as well, and some fragments are eliminated slowly during
wakefulness. We consider the FG hypothesis and propose that,
during wakefulness, the degradation of accumulating fragments is
delayed within natural protein aggregates such as postsynaptic
densities (PSDs) in excitatory synapses and in other dense protein
meshworks, owing to an impeded diffusion of the ∼3,000-kDa 26S
proteasome. We also propose that a major function of sleep involves
a partial and reversible expansion of PSDs, allowing an accelerated
destruction of PSD-localized fragments by the ubiquitin/proteasome
system. Expansion of PSDs would alter electrochemistry of synapses,
thereby contributing to a decreased neuronal firing during sleep. If
so, the loss of consciousness, a feature of sleep, would be the con-
sequence of molecular processes (expansions of protein meshworks)
that are required for degradation of protein fragments. We consider
the concept of FG sentinels, which signal to sleep-regulating circuits
that the levels of fragments are going up. Also discussed is the pos-
sibility that protein fragments, which are known to be overproduced
during an epileptic seizure, may contribute to postictal sleep and
termination of seizures. These and related suggestions, described
in the paper, are compatible with current evidence about sleep and
lead to testable predictions.
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Sleep is universal among mammals and other vertebrates.Animals with much smaller nervous systems, such as insects,
also sleep (1–8). Mechanisms that control sleep include circadian
circuits, which underlie daily rhythms of sleep and other biological
variables (9). However, circadian aspects of sleep do not define it
entirely, because sleep has the homeostatic property of becoming
longer after sleep deprivation (10, 11). In mammals, birds, and
lizards, two alternating modes of sleep have been identified, the
non-rapid eye movement (NREM) sleep and the rapid eye move-
ment (REM) sleep (12, 13). The depth of NREM sleep is yet an-
other sleep variable. In adult humans, NREM sleep occupies ∼80%
of the total sleep time. For recent reviews of sleep, see refs. 14–20.
Despite advances in the understanding of neuronal circuits as
well as genes, proteins, short peptides, and other compounds
that regulate sleep, it is largely unknown why sleep exists and
what it is for. Maladaptive aspects of sleep include elevated
dangers of predation during sleep, the neglect of territorial de-
fense and foraging for food, and the loss of parental care and
mating opportunities. It is unknown what features of sleep did
not allow these fitness costs to cause, through natural selection, a
strong shortening or elimination of sleep during evolution.
Mammals, which contain ∼109 to ∼1012 neurons, sleep several
hours per day. Insects, most of which contain significantly fewer
than 106 neurons, also sleep on the order of hours per day. Bouts
of sleep in insects vary, usually lasting about 5 min, close to
durations of NREM sleep epochs in mammals such as mice,
typically from ∼5 to ∼15 min. In adult humans, NREM sleep
epochs usually range from ∼70 to ∼120 min. In sum, one clue
about the cause of sleep is that its total duration per day is largely
unrelated to the size of a nervous system, at least within the
1,000-fold range between mammals and insects.
Reversible transitions between wakefulness and sleep are con-
trolled by neuronal circuits that reside in specific regions of the
brain (21, 22). Sleep is also regulated by the skeletal muscle, pos-
sibly through sleep-promoting (somnogenic) cytokines such as
interleukin-1 (IL-1) and tumor necrosis factor (TNFα) that can be
secreted by the muscle (23, 24). Other findings indicate that a be-
haviorally overt sleep is an emergent state that coalesces from local
sleep foci that might be, initially, single neurons (25–27). It is pos-
sible, therefore, that a cause that led to the advent of sleep during
evolution may reside in individual neurons and other individual cells,
as distinguished from higher-order settings such as networks of cells.
In what follows, we shall make a distinction between molecular-
level hypotheses about the cause/function of sleep and propositions
that are neither molecular nor overtly mechanistic. General notions
include suggestions that the function of sleep is to optimize utili-
zation of the organism’s energy flux (28) and/or to purge undesir-
able modes of interaction in neuronal networks (29). In 1995, it was
proposed that the function of sleep may be a replenishment, during
NREM sleep, of cerebral glycogen stores (30). This molecular-level
guess about a major function of sleep is still an unsettled proposi-
tion (31, 32). Other suggested causes/functions of sleep tend to be
higher-order concepts. They include the synaptic homeostasis hy-
pothesis (33) and extensive evidence for a role of sleep in memory
and learning (34, 35).
If the assumption (it remains an assumption) that the funda-
mental cause of sleep resides in individual neurons and other
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individual cells is correct, what is a molecular process(es) that
comprises the cause of sleep? Homeostatic responses of animals
to sleep deprivation that result in a longer “recovery” sleep
suggest that sleep evolved to counteract a set of molecular
processes, a form of stress that occurs during wakefulness and
impairs both neural and other organismal functions. A hypo-
thetical stressful process takes place in individual neurons, likely
in other cells as well, and may also involve extracellular spaces.
The stress keeps building up during wakefulness, impairs neural
functions and other processes, and eventually causes sleep.
Specific (largely obscure) molecular pathways act to reverse,
during sleep, a stress-mediated impairment, bringing it down to a
level at which the wakefulness can resume.
The Fragment Generation Hypothesis
In 2012, we suggested that the relevant stressful process, a spe-
cific molecular cause of sleep, is the production, during wake-
fulness, of numerous intracellular and extracellular protein
fragments that can be transiently beneficial but can also perturb,
through their cumulative and mechanistically diverse effects, the
functioning of the brain and other organs (Fig. 1) (36). A part of
the fragment generation (FG) hypothesis is the suggestion that
some natural protein fragments are removed too slowly during
wakefulness, and that the resulting accumulation of fragments
gradually impairs cognition and other processes.
In this 2012 concept, the production of intracellular and extra-
cellular protein fragments, mediated by proteases, is decreased
during sleep, specifically NREM sleep, while the removal or de-
struction of fragments is accelerated (36). It is unclear whether the
FG hypothesis is also relevant to REM sleep, as REM and wake-
fulness appear to involve similar frequencies of Ca2+ transients.
These influxes of calcium ions into the cytosol activate, in partic-
ular, calpain proteases, which generate a significant fraction of in-
tracellular protein fragments (37).
In 2013, Nedergaard and colleagues (38) showed that some
spaces between cells in the mouse brain become larger during
NREM sleep, in part through decreases of astrocyte volumes.
This change accelerates fluxes of interstitial fluid that transport
substances from extracellular spaces in the brain to lymphatic ves-
sels and eventually to the blood. These findings suggested that one
function of sleep may be to facilitate the removal of harmful ex-
tracellular substances, including, possibly, β-amyloid (Aβ) peptides
(38). In agreement with the FG hypothesis, the ∼40-residue Aβ
peptides are protein fragments. They are produced by proteolytic
cleavages of the amyloid precursor protein (APP), reside both ex-
tracellularly and intracellularly, and their levels in the brain increase
during wakefulness and sleep deprivation (39–41).
The FG hypothesis posits accumulation, during wakefulness,
of both intracellular and extracellular protein fragments (36).
The latter are produced through cleavages by extracellular and
membrane-embedded proteases. The removal of extracellular
protein fragments from the brain may be selective inasmuch as
fragments would often be soluble, in contrast to their full-length
counterparts, many of which reside in insoluble or membrane-
embedded extracellular meshworks.
Intracellular proteins, for example, the ones in the cytosol
and the nucleus, can be cleaved primarily by two sets of non-
processive proteases: calpains, which are activated by Ca2+ and/or
Fig. 1. A nonprocessive cleavage of a protein and some of its outcomes. (A) A proteolytic cut generates a new N-terminus and a new C-terminus (marked by
asterisks). (B) Two fragments resulting from a cut may either stay together indefinitely or dissociate, either rapidly or slowly. The rates of in vivo degradation
of each fragment depend, in part, on the rate of their dissociation from each other, and also on whether the neo-N-terminus and/or the neo-C-terminus
(marked by asterisks) bear destabilizing residues (marked in red), i.e., residues that can be recognized by N-degron and/or C-degron pathways (Fig. 2 and SI
Appendix, Figs. S5 and S6). Depending on specific protein fragments and their Nt/Ct residues, these pathways can destroy not only dissociated fragments but
also, selectively, either one or both of them even if these fragments are a part of a multisubunit protein complex. The diagram of two associated fragments
on the Right illustrates the outcome (one of several possibilities) in which only the neo-N-terminus is destabilizing (denoted in red), while the neo-C-terminus
(denoted in black) is not recognized by C-degron pathways.
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phosphorylation (37), and caspases, which are activated by condi-
tional dimerization and by cleavages of their precursors (42). Sig-
nificant levels of activated caspases are present even in unstressed
cells, including healthy neurons (43). A brief activation of calpains
by a Ca2+ transient leads to irreversible cleavages of many in-
tracellular proteins. Given the ubiquity of Ca2+ transients, these
cleavages take place both in neurons and in other cell types (44–47).
Activated calpains can, in turn, activate caspases (48, 49). Other
intracellular proteases, e.g., separases, paracaspases, taspases, and
cathepsins, or intramembrane proteases, e.g., secretases and
rhomboid proteases, also generate intracellular protein fragments.
Cleavage sites for caspases and calpains are present in many
intracellular proteins and are often conserved among at least
vertebrates (SI Appendix, Figs. S1–S4). More than 1,500 mam-
malian proteins are substrates of caspases (42). The roughly
300 intracellular mammalian proteins that have been identified
as substrates of calpains are, most likely, a small subset of the
actual set of substrates, as calpain cleavage sites do not comprise
a clear consensus sequence, and proteome-wide screens for
calpain substrates are just beginning (37, 44–47, 50).
A part of the FG hypothesis is the concept of FG sentinels (36).
They are defined, operationally, as somnogenic protein fragments
that signal, to sleep-regulating neuronal circuits, that the levels of
intracellular and/or extracellular protein fragments are going up.
The FG hypothesis suggests a link between fragments and epi-
lepsy. Specifically, the known upsurges, during epileptic seizures, of
extracellular and intracellular protein fragments (51–53) may di-
rectly cause the often observed postictal (postseizure) sleep.
We suggest that, during normal wakefulness, hundreds of
different protein fragments may accumulate, at low fractional
levels, in the brain and other sleep-relevant organs [such as the
skeletal muscle (23, 24)] by the time sleep begins. The overall
impact of protein fragments during wakefulness would stem from
individually small but cumulative and mechanistically diverse
effects of the sheer multitude of different fragments. If so, this
aspect of the FG hypothesis would be analogous to the recently
emerged understanding that many diseases as well as specific
phenotypes (e.g., human height) are underlied by hundreds of
variant genomic loci acting together, with each variant having a
small effect (54, 55).
Degradation of Protein Fragments by N-Degron and
C-Degron Pathways
Permanently postmitotic cells, such as, for example, mature
neurons or myotubes (elongated multinucleated cells of the
skeletal muscle), do not have the option of removing protein
fragments through a dilution upon cell divisions. Consequently,
either an ongoing or (transiently) delayed degradation of accu-
mulating fragments is a necessity for such cells.
A cleavage of a protein generates a new N-terminus and a new
C-terminus (Fig. 1). Thus, degradation signals (degrons) that are
particularly relevant to protein fragments are N-degrons and
C-degrons (Figs. 1 and 2 and SI Appendix, Figs. S5 and S6) (50, 56–
64). The main determinant of N-degron is a destabilizing N-
terminal (Nt)-residue of a protein. Other determinants of
N-degron include a protein’s internal lysine (the site of poly-
ubiquitylation). N-degron pathways (they were previously called
“N-end rule pathways”) comprise proteolytic systems whose
unifying feature is their ability to recognize N-degrons, thereby
causing the degradation of targeted proteins by the 26S protea-
some or autophagy in eukaryotes and by the ClpAP protease in
bacteria (Figs. 1 and 2 and SI Appendix, Fig. S5) (57).
Initially, most N-degrons are pro–N-degrons. They can be con-
verted to N-degrons through a protease-mediated cleavage that
exposes a destabilizing Nt-residue in the resulting C-terminal (Ct)-
fragment. Proteases that include calpains, caspases, and separases
have been shown to generate N-degrons in vivo through their
cleavages of intracellular proteins (39, 50, 56, 57, 60). A different
and mutually nonexclusive route to N-degrons is through Nt-
modifications of proteins, including enzymatic Nt-acetylation, Nt-
deamidation, Nt-arginylation, Nt-leucylation, and Nt-formylation of
the α-amino groups of Nt-residues (Fig. 2 and SI Appendix, Fig. S5)
(57, 65).
Although the identity of a destabilizing Nt-residue, in a natural
Ct-fragment of a specific protein, can vary, in that Ct-fragment,
from one animal species to another, the destabilizing nature of this
(varying) residue is often strongly preserved (Fig. 2 and SI Appen-
dix, Figs. S3–S5). Thus, remarkably, it is destabilizing activity of a
neo-Nt-residue of a protein fragment (i.e., not the residue’s identity
per se) that is under positive selection during evolution.
All 20 amino acids of the genetic code have been shown to act, in
cognate sequence contexts, as destabilizing Nt-residues (Fig. 2 and
SI Appendix, Fig. S5). Consequently, many cellular proteins and
their natural fragments are short-lived N-degron substrates. The
proteasome-mediated protein degradation by N-degron pathways is
subunit selective, i.e., a targeted subunit (or its fragments) can be
destroyed without damaging the rest of a protein complex (57).
Conditional protein degradation by N-degron pathways has been
shown to regulate many biological processes in all eukaryotes, from
fungi and protists to animals and plants (56–59, 66).
C-degrons are degradation signals whose main determinant is a
destabilizing Ct-motif (SI Appendix, Fig. S6) (57, 62–64). C-degrons
and N-degrons are topologically analogous, can be cocreated by a
single cut, and can be related functionally (Figs. 1 and 2 and SI
Appendix, Figs. S5 and S6). For example, many calpain cleavage
sites would yield, upon a cleavage of a protein, a putative (or
confirmed) N-degron in the resulting Ct-fragment and a spatially
adjacent putative C-degron in the sibling Nt-fragment (Figs. 1 and 2
and SI Appendix, Figs. S1, S3, S5, and S6). Thus, both fragments of
a cleaved subunit in a protein complex can be destroyed through
fragment-selective attacks by cognate N-degron and C-degron
pathways, while preserving the rest of the complex (57).
In sum, the degradation of natural protein fragments, many of
which, according to the FG hypothesis, are relevant to sleep
physiology (36), would be carried out, to a large extent, by N-
degron and C-degron pathways.
Reasons for Generating Protein Fragments, and Associated
Costs
The evolutionary conservation of cleavage sites in intracellular
and extracellular proteins (SI Appendix, Figs. S1–S4) suggests a
positive selection for these sites. With caspases, the value of
retaining, during evolution, their cleavage sites in individual
proteins stems, in part, from the functions of caspases during
apoptosis, a pathway of programmed cell death that sculpts both
embryos and adults (42, 60). Cleavages by caspases mediate
death-unrelated functions as well, including cell differentiation
and long-term memory (43, 67).
As to calpains, cited below are examples of beneficial calpain-
mediated cleavages. (i) Calpains regulate cell–cell interactions
and intracellular cytoskeletons. For example, cortactin, an actin-
binding protein, is cleaved by calpain-2 at a specific site. This
(regulated) cleavage controls actin filaments, cell motility, and
processes that include the inhibition of branching in axons (68,
69). (ii) In the marine snail Aplysia californica, type-C in-
tracellular protein kinases are cleaved by calpains, yielding type-
M (PKM) kinases that comprise unconditionally active catalytic
domains and underlie the maintenance of memory in Aplysia
(70). (iii) Pyroptosis, an immunostimulatory form of pro-
grammed cell death that can be physiologically beneficial, in-
volves calpain-mediated cleavages of vimentin, a cytoskeletal
protein (71). A pathologically high or prolonged calpain activity,
which can occur in a disease, e.g., an intractable epilepsy, can be
lethal for cells. However, both the first two examples above (68–
70) and other known cases make clear that calpain-generated
protein fragments are often not about cell death.
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The FG hypothesis has emphasized a seemingly trivial but
possibly significant dichotomy: A cleavage of a protein generates
two fragments (36). Consequently, effects of a potentially ben-
eficial fragment are linked to a possibly detrimental effect of the
sibling fragment. This attribute of a proteolytic cleavage, i.e., a
pervasive mechanistic link between a beneficial (at least in part)
fragment and its often detrimental sibling fragment, might be
relevant to the unexplained fact that sleep, despite its fitness
costs (see Introduction), has not been strongly shortened or
eliminated during evolution.
Gain-of-function features of protease-generated protein frag-
ments may have become entrenched in early eukaryotes through
being adaptive in some ways and despite being costly in other
respects, given potentially detrimental sibling fragments and the
necessity of destroying fragments in postmitotic cells. Early eu-
karyotes were, most likely, not obligatorily multicellular. If so,
they were not postmitotic either and therefore could deal with
less than beneficial fragments and other such proteins not only
through degradation but also through cell divisions, either sym-
metric (dilution of fragments) or asymmetric ones, which could
segregate some proteins (including aggregates) into one of two
daughter cells. If so, an emergence, in early single-cell eukary-
otes, of diverse proteases that generated protein fragments
(some of which were beneficial) may have incurred relatively
low fitness costs. As a result, molecular circuits based on partly
beneficial protein fragments may have become entrenched.
This disposition, which is difficult to reverse, would become a
problem later, when some eukaryotes evolved to be obligato-
rily multicellular and developed a division of labor among
cells of different types, including terminally differentiated,
postmitotic cells.
In this FG-based scenario, the advent of sleep during evolu-
tion may have been caused, at least in part, by the emergence of
postmitotic cells, such as neurons and myotubes, in multicellular
eukaryotes. If so, some functions of modern sleep as well as
complexities of its regulation may be later additions to simpler
versions of sleep that coevolved with nonprocessive proteases
that generated protein fragments and with processive proteasome-
mediated pathways that recognized and destroyed these fragments.
On a Possible Delay in Degradation of Fragments During
Wakefulness
The FG hypothesis posits that sleep would be up-regulated by
processes that increase the levels of protein fragments (36).
Epileptic seizures are known to up-regulate fragments (51–53)
and sleep deprivation is predicted to do so (36). These processes
involve excitatory (glutamatergic) synapses, which contain post-
synaptic densities (PSDs). A PSD is a disk-shaped aggregate
(meshwork) of roughly 500 different proteins. PSDs are located
underneath synapse-encompassing patches of the plasma mem-
brane in dendritic spines of postsynaptic neurons. PSDs are rich
in scaffold/cytoskeletal proteins (72–81). Specific scaffold pro-
teins bind to cytosolic domains of glutamate receptors such as
AMPAR, NMDAR, and mGluR1, transiently trapping these and
other transmembrane proteins within a PSD (80). PSDs form,
grow, adopt a range of shapes, and disappear in ways that de-
pend on fates of dendritic spines in which PSDs reside (81).
PSDs contain both calpains and caspases (37, 82–84). Once
activated, these proteases can cleave cytoskeletal proteins as well
as cytosolic domains of PSD-localized transmembrane receptors.
Owing to their location, immediately beneath the plasma mem-
brane and within regions of Ca2+ transients, PSDs encounter
highest local Ca2+ concentrations in postsynaptic neurons and
are, therefore, major sites at which Ca2+-activated calpains
generate protein fragments.
Studies of oligomeric proteins described a number of cases in
which a cleaved protein subunit stays embedded (as one or both
of its fragments) within a complex. Some oligomeric proteins
continue to be active, at least for a while, even after cleavages of
Fig. 2. The mammalian Arg/N-degron pathway. Yellow ovals denote the rest of a protein substrate. Nt-residues are denoted by single-letter abbreviations.
This pathway targets proteins for degradation through their specific unacetylated Nt-residues (50, 56–61). See SI Appendix, Fig. S5 for other N-degron
pathways. “Primary,” “secondary,” and “tertiary” refer to mechanistically distinct classes of destabilizing Nt-residues. NTAN1 and NTAQ1 are Nt-amidases
that convert, respectively, the tertiary destabilizing Nt-Asn and Nt-Gln to Nt-Asp and Nt-Glu. C* denotes oxidized Nt-Cys, either Cys-sulfinate or Cys-sulfonate,
produced in vivo through reactions that require oxygen and nitric oxide. The ATE1 Arg-tRNA-protein transferase (R-transferase) conjugates Arg, a primary
destabilizing residue, to Nt-Asp, Nt-Glu, and (oxidized) Nt-Cys. Hemin (Fe3+-heme) inhibits the enzymatic activity of R-transferase and accelerates its deg-
radation in vivo. Hemin also binds to UBR1/UBR2 E3s and inhibits specific aspects of their activity (50, 56–61). “Type 1” and “type 2” refer, respectively, to two
sets of primary destabilizing Nt-residues, basic (Arg, Lys, His) and bulky hydrophobic [Leu, Phe, Trp, Tyr, Ile, and also Met, if the latter is followed by a bulky
hydrophobic residue (Ф)]. These Nt-residues are recognized by two substrate-binding sites (type 1 and type 2) of N-recognins, the pathway’s E3 Ub ligases
UBR1, UBR2, UBR4, and UBR5. Besides recognizing Arg/N-degrons, these E3s contain, in addition, specific binding sites that are exposed conditionally and
recognize internal (non-Nt) degrons of proteins that lack Arg/N-degrons (56–59).
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their essential subunits, which remain embedded in a complex as
fragments (61, 85–87).
We suggest that a delay in destroying a fragment that is formed
and retained in a protein complex within a PSD may become
particularly pronounced owing to a difficulty that is unique to dense
protein meshworks: In addition to an often slow or negligible
dissociation of subunit’s fragments from a (cleaved) oligomeric
complex, these fragments may also be shielded from the bulky
polyubiquitylation–degradation machinery, inasmuch as both frag-
ments and protein complexes that contain them would reside in
diffusion-impeding meshworks such as PSDs (Fig. 3).
PSDs are not the only natural aggregates in which a diffusion of
large complexes (particularly the ∼3,000-kDa 26S proteasome) may
be slow or negligible. For example, analogous meshworks of cyto-
skeletal and transmembrane proteins are also present on the
postsynaptic sides of inhibitory synapses. Such synapses usually do
not involve dendritic spines but form directly on dendrites (88).
Gephyrin (GPHN), a postsynaptic scaffold protein in in-
hibitory synapses, can be cleaved, at a specific site, by activated
calpains (88). As to PSDs of excitatory synapses, they contain
many calpain substrates, including PSD95, PSD93, PSD97,
GRIP1, spectrin (SPTBN1), ezrin (EZR), stargazin (CACGN2),
p35 (CDK5R1), and cytosolic domains of PSD-entrapped
transmembrane proteins such as NMDAR, AMPAR, mGluR1,
and N-cadherin (37, 73, 74, 77). For most of these proteins,
specific physiological functions of cleavages by calpains are still
unknown. The PSD-localized calpain substrates cited above are
but a subset of a future comprehensive list.
Many calpain/caspase-mediated cleavages of PSD proteins pro-
duce N-degrons and/or C-degrons in newly generated protein
fragments (Figs. 1 and 2 and SI Appendix, Figs. S1–S6) (50, 60).
Therefore, a delay in degradation of protein fragments within, e.g.,
a PSD would be caused by the conjectured steric inaccessibility of at
least some PSD-localized protein fragments, rather than by a
scarcity of degrons in these fragments (Fig. 2 and SI Appendix, Figs.
S1 and S2). In contrast, “soluble” degron-bearing intracellular
fragments, produced through cleavages of proteins outside of
meshworks, would be efficaciously destroyed, during either wake-
fulness or sleep, by the ubiquitin (Ub)–proteasome system (UPS)
that includes N-degron and C-degron pathways.
The proposed impediment (steric hindrance) to the de-
struction of fragments that are generated within PSDs and other
dense meshworks may stem from electrochemical constraints on
the design of postsynaptic PSDs. These meshworks may have to
be sufficiently compact (dense) for allowing neurons to fire
frequently enough during wakefulness. If so, the necessity of
dense PSDs during wakefulness, and the cost of that necessity—
an impairment of protein degradation within PSDs—may be a
fundamental molecular-level reason for the existence of NREM
sleep. A transition from wakefulness to a different regimen, re-
ferred to as sleep, may deal with the problem of steric hindrance
through a process proposed below.
Might PSDs Reversibly Expand During NREM Sleep?
During wakefulness, the meshwork of a PSD is suggested to be
dense enough to be a significant obstacle to entry and diffusion
of large protein complexes that include, particularly, the ∼3,000-
kDa 26S proteasome (Fig. 3). What follows is a specific hy-
pothesis, and its ramifications, about sleep–wake transitions in
PSDs and analogous protein meshworks.
1) It is proposed that the onset of NREM sleep involves,
among other things, a reversible physical expansion (loosening)
of the PSD meshwork (Fig. 3). The envisioned expansion may be
caused by any number of specific protein modifications by PSD-
localized enzymes that carry out, for example, phosphorylation–
dephosphorylation and/or acetylation–deacetylation of specific
PSD proteins. As a result, some (but not all) interprotein dis-
tances in PSDs would become larger, specifically large enough to
allow a relatively unimpeded diffusion of the ∼3,000-kDa 26S
proteasome and Ub ligase complexes within an expanded PSD
(Fig. 3). This alteration would accelerate degradation of fragments
Fig. 3. On the possibility of a reversible expansion of natural dense mesh-
works during sleep. A partial and reversible expansion of postsynaptic densities
(PSDs) and analogous protein aggregates is the hypothetical reason for a
proposed delay in degradation of PSD-localized protein fragments during
wakefulness. (A) Schematic of a dendritic spine that contains a PSD (solid black
shape) during wakefulness. (B) Same as in A but during NREM sleep, with an
expansion of PSD indicated by interweaved black curves, and with 26S pro-
teasome particles (red circles) having access to the interior of PSD. (C) Notations.
Transmembrane proteins, denoted by colored ovals and rectangles, are depic-
ted not to scale (all of these proteins are smaller than the 26S proteasome). Red
circles denote the ∼3,000-kDa 26S proteasome particles, located, according to
this model, largely outside PSDs during wakefulness but partly within PSDs
during NREM sleep. See the main text for details.
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that had been generated during wakefulness within PSDs and
analogous meshworks. The nature of expansion-regulating enzy-
matic modifications of PSD proteins remains to be determined. It
has been shown, for example, that phosphorylation of PSD95 and
other PSD proteins can influence their intermolecular and intra-
molecular interactions (89).
In sum, it is proposed that protein fragments are generated
within PSDs and related natural meshworks during wakefulness
(owing to Ca2+ transients and activation of at least calpains), and
that PSDs, in that state, are too dense for an entry and diffusion
of the ∼3,000-kDa 26S proteasome. A reversible PSD expansion,
by allowing a relatively unimpeded diffusion of the 26S protea-
some within PSDs, makes possible the destruction of PSD-
localized fragments that formed during wakefulness. By down-
regulating excitability of postsynaptic neurons, expansions of
PSDs would lead to an overall decrease of excitatory neuronal
activity, and thereby would shift the system to a different regi-
men, sleep. In this model, at least NREM sleep is the “price” of
being able to efficaciously destroy PSD-localized protein frag-
ments that accumulated during wakefulness (Fig. 3).
It should be noted that a compact PSD, during wakefulness, is
not necessarily expected to lack 26S proteasome particles alto-
gether. The key idea is that the 26S proteasome can neither ef-
ficaciously diffuse within a compact PSD nor readily enter it.
2) The notion of a reversible PSD expansion during NREM
sleep (Fig. 3) presumes that transmembrane receptors, which are
dynamically (transiently) trapped, within PSDs, by scaffold
proteins would continue to be largely retained in expanded
PSDs as well. Thus, the envisioned expansion of PSDs would be
not only moderate but also selective in regard to specific con-
tacts, as the proposed expansion would preserve interactions of
scaffold proteins with cytosolic domains of PSD-localized
transmembrane proteins.
3) Firing, by a postsynaptic neuron, of an action potential
results from multiple inputs, including Ca2+ transients at neu-
ron’s dendrites. The known decrease of the frequency of Ca2+
transients and action potentials during NREM sleep (21) would
be caused, at least in part, by the envisioned physical expansion
of PSDs during sleep.
4) If a decrease of firing by neurons during NREM sleep
would be found to be actually caused, in part, by a physical ex-
pansion of PSDs, such an understanding would also explain why
PSDs cannot stay expanded all of the time, inasmuch as the
mean frequency of firing must be higher during wakefulness. In
sum, a lower overall activity of neurons during NREM sleep is
suggested to be caused, in part, by an expansion of PSDs and
analogous protein meshworks.
5) It is unknown why sleep is accompanied by the loss of
consciousness. A quiet wakefulness would seemingly suffice, but
this is not what actually happens. Consciousness requires activity
of many neuronal circuits, particularly of the cortico-thalamic
system (90). If the proposed expansions of PSDs and analogous
meshworks (Fig. 3) actually take place during NREM sleep, the
necessity of PSD expansion for destroying accumulated protein
fragments and the (presumed) incompatibility of expanded PSDs
with frequent firing by neurons would suffice to account for the
loss of consciousness during at least NREM sleep. In this model,
the loss of consciousness is caused by expansion of PSD mesh-
works and is an outcome of molecular constraints (a delayed
destruction of protein fragments) that underlie the fundamental
cause/function of sleep. We are not aware of other suggestions
about a specific molecular-level cause of losing consciousness
during sleep. A nonmechanistic explanation, proposed a century
ago, is that the loss of consciousness prevents new experiences
and thereby assists memory consolidation during sleep (91).
6) One prediction of the PSD-expansion model is that post-
synaptic neurons would contain, during wakefulness, the 26S
proteasome in dendritic spines, i.e., spatially close to PSDs, but
largely not within PSDs (Fig. 3). Current evidence is not inconsis-
tent with this prediction. The autophosphorylated Ca2+/calmodulin-
dependent protein kinase IIα (CamKIIα), a component of spines,
has been shown to bind to the 26S proteasome (92). Up-regulation
of neuronal activity causes the movement of CamKIIα from den-
dritic shafts to nearby spines, in which CamKIIα acts as a “sink” for
the 26S proteasome, increasing its entry into spines (92). These
results were obtained using light microscopy, which does not dis-
tinguish between locations of specific proteins within a PSD vs. the
rest of a spine. An electron microscopy study suggested that the
movement of CamKIIα into spines concentrates this kinase (and
also, by inference, the associated 26S proteasome particles) im-
mediately beneath the dense PSD meshwork (79). In sum, it re-
mains to be determined exactly where the 26S proteasome resides
within a spine, and whether the distribution of proteasome particles
changes during wakefulness vs. NREM sleep.
7) Varying in size from ∼100 to ∼1,000 kDa, Ub ligase com-
plexes are smaller than the ∼3,000-kDa 26S proteasome.
Therefore, a variant of the PSD-expansion model is that at least
some Ub ligases, as well as ∼100-kDa Ub-activating enzymes
(let alone the 9-kDa Ub) should be able to diffuse within com-
pact PSDs and analogous protein meshworks during wakeful-
ness, in contrast to the 26S proteasome. If so, these Ub ligases
could target and polyubiquitylate their PSD-localized substrates,
including protein fragments, even during wakefulness. In con-
trast, the 26S proteasome is envisioned to gain an efficacious
access to the interior of PSDs either largely or solely during
NREM sleep (Fig. 3).
Interestingly, behavioral tests that retrieved a specific long-
term memory in mice were found to increase the in vivo poly-
ubiquitylation of hippocampal proteins (93). Polyubiquitylated
proteins are recognized and destroyed by the 26S proteasome.
Increased in vivo levels of polyubiquitylated hippocampal pro-
teins suggest that their proteasome-mediated degradation
was the rate-limiting step under those conditions. (If poly-
ubiquitylation, rather than degradation, were the rate-limiting
step, polyubiquitylated proteins would not be expected to accu-
mulate.) The authors (93) did not consider this interpretation,
but their data are consistent with the possibility that proteins in
their preparations (a significant fraction of those proteins re-
sided in PSDs) were polyubiquitylated in vivo but not degraded,
as yet, under conditions of memory retrieval experiments with
awake mice.
8) Regulation of sleep involves neurons that fire frequently
during wakefulness but are largely silent during, e.g., NREM
sleep. Conversely, neurons that maintain NREM sleep are active
during NREM but relatively silent during wakefulness (15). The
proposed PSD-expansion model may also be relevant to neurons
that maintain NREM sleep, except that this circuit would
operate “in reverse”: Neurons that fire frequently during NREM
sleep but tend not to fire during wakefulness may accumulate
protein fragments during NREM sleep and destroy them later,
during wakefulness.
9) A particularly deep NREM sleep, called a “slow-wave”
sleep and defined, in part, by its electroencephalographic fea-
tures, is up-regulated in cortical regions of the brain that have
been recently hyperactive (35). Molecular/mechanistic aspects of
a slow-wave NREM sleep are largely unknown. Given the PSD-
expansion model (Fig. 3), one possibility is that a deeper NREM
sleep may involve a stronger PSD expansion. This would lead to
a less impeded diffusion of the 26S proteasome within PSDs and,
consequently, to a faster destruction of PSD-localized fragments
and other proteins. According to the FG hypothesis (36), protein
fragments would be overproduced in a hyperactive region of the
brain, in comparison with a less exercised region. If so, a PSD-
expansion model in which a greater depth of NREM sleep sig-
nifies a stronger PSD expansion (and, consequently, a faster
degradation of fragments; Fig. 3) may account for the observed
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connection between hyperactivity of a cortical region and the
depth of its subsequent NREM sleep.
10) Durations of NREM sleep epochs vary widely during sleep
and vary even more among different species. For example, hu-
man NREM epochs, during a single night, range from ∼70 to
∼120 min, and alternate with (typically) shorter REM sleep
epochs. In contrast, while the total durations of mouse and hu-
man sleep are comparable (several hours per day), a mouse
sleeps in much shorter NREM epochs, usually between ∼5 and
∼15 min (1).
What is the benefit of a NREM epoch as brief as 5 min?
Enzymatic modifications that mediate the proposed expansion of
PSDs upon a NREM sleep (Fig. 3) would be expected to occur
rapidly, on the scale of seconds. The ensuing proteasome-
mediated processive destruction of protein fragments within an
expanded PSD would be irreversible. Consequently, even a brief
NREM epoch would attain, by its end, a ratchet-like “improve-
ment,” i.e., a decrease in the load of protein fragments. If so,
specific durations of NREM epochs would be relatively un-
important (in contrast to the total duration of NREM sleep), in
agreement with the observed scatter of NREM sleep epochs.
11) The FG hypothesis is relevant to intracellular and extra-
cellular settings (including ones outside the brain) that involve
accumulation of protease-generated protein fragments whose
destruction entails a significant delay. At least for intracellular
proteins, this delay would happen either because one or both
fragments resulting from a cut would still reside in a cleaved but
otherwise intact protein complex, or because the ∼3,000-kDa
26S proteasome cannot get access to fragments (owing to their
location within a dense meshwork), or for both of these (very
different) reasons together. One example of meshworks outside
the brain are natural cytoskeletal aggregates that underlie the
architecture of skeletal muscle and its myotubes (94). Conse-
quently, a delayed destruction of protein fragments (accumulated
during wakefulness) within protein meshworks of muscle cells may
be relevant to the known role of skeletal muscle in sleep regulation
(24) and may also play a role in muscle fatigue.
Verification of the PSD expansion/compaction model (Fig. 3)
and other aspects of the FG hypothesis is a tractable challenge,
since all proposed conjectures are concrete enough to be falsi-
fiable. If the FG hypothesis proves correct at least in outline, it
would imply that the dynamics of intracellular and extracellular
protein fragments, in the brain and in other organs, may underlie
not only molecular-level roles of sleep but its higher-order
functions as well, including the extensively documented role of
sleep in learning and memory (34, 35). Several lines of evidence
indicate that memory and learning involve natural protein frag-
ments, both in mammals and in the Aplysia marine snail (67, 70).
Protein fragments are also likely to play a role in the complex
dynamics of dendritic spines (33, 95).
Up-Regulation of Protein Fragments in Epilepsy and Their
Possible Links to Sleep
For most extracellular or intracellular proteins, the percentages
of their cleavages during normal wakefulness are envisioned, in
the FG hypothesis, to be low (<10%, and often <<10%). In
addition, not all fragments are expected to accumulate during
wakefulness, as some of them would be destroyed efficaciously.
Generation of fragments can be accelerated in a disease, for
example, during epileptic seizures, which involve higher fre-
quencies of Ca2+ transients and therefore an increased activation
of at least calpain proteases. Seizures have been shown to up-
regulate cleavages of intracellular and extracellular proteins
strongly enough to make specific protein fragments in the brain
readily detectable by immunoblotting (51–53).
Descriptions of human and rodent epilepsy mention a fre-
quent occurrence of sleep, either immediately or soon after a
seizure (96–98). In agreement with this evidence, our own sur-
veys of Internet chat rooms that facilitate correspondence among
epilepsy patients indicated that postictal sleep is a recurrent
subject of their discussions. “I slept it off” and other remarks to
that effect are frequent descriptions of postictal experiences that
one encounters at these websites.
Electroconvulsive therapy (ECT), a version of induced seizure,
is still used to treat an otherwise intractable depression. ECT is
also associated with an enhanced sleep of a patient soon after
treatment, as remarked upon, repeatedly, by ECT patients and
their physicians (99). For example: “People often found they were
very sleepy immediately after their ECT treatment and wanted to
go to bed.” “Her daughter would sleep for up to twelve to fourteen
hours afterwards” (after ECT treatments) (www.healthtalk.org/
peoples-experiences/mental-health/electroconvulsive-treatment/side-
effects-having-ect).
Two more descriptions of a postictal sleep: “If the convulsion
became more pronounced his orderlies quickly brought someone
to him whose presence he found relaxing. . . . ‘Peter Alexeevich,
here is the person to whom you wished to speak,’ his worried
orderly would say and then withdraw. The Tsar would lie down
and place his shaking head on the woman’s lap and she would
stroke his forehead and temples, speaking to him softly and re-
assuringly. Peter would fall asleep, and when he awoke an hour
or two later, he was always refreshed and in far better humor
than he had been before” (100).
“A boy had an epileptic seizure. I’d never seen one. I knew
something was going on behind me but didn’t turn around to
look until the boy was asleep on the floor. He was snoring and his
mother stood over his body while his sister ran to use the pay
phone” (101).
The FG hypothesis predicts postictal sleep, given the dem-
onstrated upsurges of protein fragments in the brain that are
caused by seizures (51–53). For the same reason, a prolonged but
reversible comatose state, upon a relatively mild physical brain
trauma, may also be caused, in part, by protein fragments that
are produced by up-regulated Ca2+ transients (which activate
calpains) in injured cells, and by upswings of extracellular pro-
teases. A reversible coma of this kind, while not nearly as re-
versible as a NREM sleep, may be mechanistically analogous to
sleep through their common attribute of protein fragments, with
much higher levels of fragments in the case of a temporary coma.
Most seizures in humans are spatially localized and self-
terminating. (Seizures lasting significantly longer than 10 min are
often fatal.) How a seizure manages to stop is not well un-
derstood. Processes that would counteract a seizure include a
Na+-dependent K+ efflux that hyperpolarizes the plasma mem-
brane and thereby reduces its excitability; a hyperpolarizing in-
flux of chloride ions, via γ-aminobutyric acid (GABA) ionotropic
receptors; a decrease of excitatory neurotransmitter glutamate in
hyperactive presynaptic neurons; and up-regulation of neuro-
modulators, such as adenosine and endocannabinoids (102, 103).
Protein fragments that are overproduced during a seizure may
cause not only a postictal sleep but may also act to reduce ex-
citability of neurons during a seizure. The verifiable possibilities,
below, are neutral in regard to identities of fragments, which
remain to be identified. (i) An extracellular fragment that is
relevant to seizure termination would be overproduced locally,
via a seizure-enhanced proteolytic cleavage of an extracellular
(or partly extracellular) full-length protein. Such a fragment
would act through its binding, largely within the region of
seizure, to a cognate neuronal surface-exposed protein, e.g., an ion
channel. The fragment would act as an antagonist of neuronal
excitability. (A full-length precursor of this fragment would be
inactive as an antagonist.) (ii) A mutually nonexclusive possi-
bility involves upsurges of Ca2+ transients and increases of
seizure-suppressing intracellular protein fragments (51–53).
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Hypersomnolence of Patients with Calpain-Activating
Wolfram Syndrome
The FG hypothesis predicts that sleep would be enhanced by an
up-regulation of calpain activity (36). Wolfram syndrome involves
early-onset diabetes and neurodegeneration, including optic nerve
atrophy (104). This recessive birth defect is caused by mutations in
WFS1 or WFS2, which encode proteins embedded in the endo-
plasmic reticulum membrane (105). One function of WFS1 and
WFS2 is to down-regulate the activity of calpain-2. Cells of Wol-
fram syndrome patients and other human or mouse cells with de-
creased (or absent) WFS1 or WFS2 exhibit abnormally high calpain
activity and increased levels of calpain-generated fragments of (at
least) spectrin, a natural substrate of calpains (105).
In agreement with the FG hypothesis, a significant but under-
explored feature of the Wolfram syndrome is hypersomnolence, an
excessive daytime sleepiness often accompanied by a prolonged
nighttime sleep (104). It would be, therefore, informative to in-
vestigate the hypersomnolence of Wolfram syndrome patients and
to analyze sleep in WFS1/WFS2-lacking mice (105) vis-à-vis protein
fragments in these settings.
Other human sleep disorders that involve hypersomnolence [but
no narcolepsy (106)] occur in 1 out of ∼10,000 births and are re-
ferred to as idiopathic (cause unknown) conditions (https://www.
orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&Expert=33208).
Both the FG hypothesis and hypersomnolence of Wolfram syn-
drome patients suggest a screening approach in which cells from
patients with idiopathic hypersomnolence disorders would be ex-
amined for an up-regulation of calpain activity and increased gen-
eration of, e.g., spectrin fragments. This can be done using white
blood cells as well as primary fibroblasts from skin biopsies.
FG Sentinels
An FG sentinel is defined as a protein that signals, to sleep-
regulating circuits, that the levels of some protein fragments, the
ones that the sentinel reports about, are going up (36). This
would couple the levels of fragments to outputs of sleep-
regulating circuits in the brain.
A precursor of an FG-sentinel that reports, for example, about
levels of calpain-generated protein fragments would be a protein
that is inactive as a sentinel and contains one or more calpain
cleavage sites. A cleavage of this protein by a calpain would
confer, on at least one of resulting fragments, the ability to act as
an FG sentinel. Analogous designs can underlie a sentinel spe-
cific for caspases or a sentinel for, e.g., extracellular metal-
loproteases. Such sentinels would react not to fragments
themselves but to an up-regulation of a protease(s) that gener-
ates specific classes of fragments. The concept of FG sentinels,
which remains to be verified, does not place a priori constraints
on mechanisms through which an FG sentinel would actually
function. Cited below are a few (out of many) plausible but far
from certain candidates for FG sentinels.
The Panx1 Pannexin Channel. ATP can be released from cells by
vesicular exocytosis and also through transmembrane channels
such as Panx1, which can be activated by effectors that include
Ca2+ transients (107). Extracellular ATP can be converted, by
plasma membrane-embedded nucleotidases, to extracellular
adenosine, a natural somnogen (18). Extracellular ATP can also
increase proteolytic processing and secretion of inflammatory
cytokines, including IL-1 and TNFα. They, too, can act as som-
nogens (23). It has been shown that a caspase-mediated cleavage
of Panx1 (at a cleavage site conserved during vertebrate evolu-
tion) activates Panx1 as an ATP release channel (108). Thus, a
caspase-generated Nt-fragment of Panx1 is a potential FG sen-
tinel that can up-regulate extracellular ATP and thereby signal,
through both adenosine increases and upsurges of inflammatory
cytokines, about the levels of fragment-producing caspase ac-
tivities in a cell. (There is no evidence, so far, about whether or
not Panx1 might also be cleavable by calpains.)
Calcineurin. Calcineurin (CaN) is a ubiquitously expressed
Ca2+/calmodulin-dependent Ser/Thr phosphatase. In Drosophila,
both strong increases and strong decreases of CaN activity have been
shown to inhibit sleep (109, 110). CaN is a heterodimer of the
catalytic A-subunit and regulatory B-subunit. In the absence of
Ca2+, the A-subunit of CaN is autoinhibited by a domain of the
same subunit. The A-subunit can be cleaved by a calpain or
caspase at two different but close by sites. Remarkably, either
one of those cleavages would separate the autoinhibitory and
catalytic domains of the A-subunit, thereby converting a regu-
lated CaN phosphatase into an unconditionally active one (111,
112). Since a moderate increase of the phosphatase activity of
CaN is somnogenic (109), a physiologically relevant activation of
CaN through a cleavage of some of its molecules by a calpain or
caspase may underlie the function of CaN as an FG sentinel,
a verifiable proposition.
Aβ Peptides. The ∼40-residue Aβ peptides are produced by pro-
teolytic cleavages of the APP protein. Short-term physiological
effects of Aβ peptides are many and include, for example, a
suppression of specific aspects of cannabinoid receptor activity
(113). Extracellular/intracellular levels of Aβ peptides in the
brain increase during both wakefulness and sleep deprivation
(40, 41). Might Aβ peptides function as FG sentinels? Available
evidence neither supports nor contradicts this idea. Other po-
tential FG sentinels can be cited as well, but these examples
suffice to define the concept.
Concluding Remarks
This paper considers the 2012 FG hypothesis about the funda-
mental cause of sleep (36), making FG concepts more detailed
through several ideas.
One of them is the possibility of an impeded diffusional access,
of the UPS proteolytic machinery (particularly the ∼3,000-kDa
26S proteasome), to dense protein meshworks such as PSDs of
excitatory synapses and other natural protein aggregates during
wakefulness (Fig. 3). An impeded diffusion of the 26S protea-
some in these aggregates is proposed to be the reason for a
(presumed) slow or negligible destruction of protein frag-
ments that are produced during wakefulness within PSDs and
analogous meshworks.
Fragments that form within dense natural aggregates during
wakefulness and are relevant to sleep may be present not only in
the brain but also in quasipermanent cytoskeletal meshworks that
underlie the architectures of other organs, such as the skeletal
muscle and its myotubes. If so, a slow or negligible degradation of
protein fragments within cytoskeletal aggregates of the muscle
during wakefulness might be relevant to the demonstrated in-
volvement of muscle in the regulation of sleep (24).
Protein fragments that accumulate during wakefulness are
proposed to be destroyed faster during NREM sleep, owing to a
(hypothetical) enzymatically controlled and reversible expansion
of PSDs and analogous natural meshworks (Fig. 3). The envi-
sioned PSD expansion during NREM sleep would be moderate
but significant enough to allow access, within PSDs, by particles
such as the ∼3,000-kDa 26S proteasome.
Extracellular cytoskeletal protein meshworks, including, possibly,
perineural nets, may also undergo reversible cycles of expansion
(during NREM sleep) and contraction (during wakefulness). An
expansion would facilitate elimination of extracellular protein
fragments that accumulate during wakefulness.
FG sentinels would convey to sleep-regulating circuits that the
levels of protein fragments are going up. Potential FG sentinels
include fragments of cytoskeletal proteins, transmembrane
channels, kinases, and phosphatases. Somnogenic cytokines such
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as TNFα and IL-1 (23) might also function as FG sentinels, if the
proteolytic processing and secretion of these cytokines by, e.g.,
the skeletal muscle during wakefulness could be shown to be
increased in response to higher levels of protein fragments in
the muscle.
It is also proposed that the known overproduction of extra-
cellular and intracellular protein fragments during epileptic sei-
zures may be a cause of postictal sleep and may also contribute
to seizure termination.
The notion that a sufficiently dense meshwork would impede,
with physiological consequences, a diffusion of large particles
within the meshwork may be relevant not only to PSDs. Analo-
gous settings may include the sarcomeres of skeletal and cardiac
muscles, and also nucleosomal fibers of chromatin, some of
which are associated with the 26S proteasome and other UPS
components (114). Sleep up-regulates chromosome dynamics (a
measure of three-dimensional mobility of chromatin domains in
the nucleus) and facilitates repair of double-strand breaks in
DNA (115, 116). At least the latter process involves the 26S
proteasome (117). One possibility is that a decreased or halted
diffusion of the 26S proteasome within (reversibly) compacted
chromosomal regions may be a part of circuits that regulate the
proteasome-mediated destruction of histone fragments and
other proteins in the vicinity of DNA. [Subsets of nucleosomal
histones are cleaved by nonprocessive proteases during cell dif-
ferentiation, stresses, and other transitions (118, 119).]
The set of testable conjectures that comprise the FG hypothesis is
compatible, to our knowledge, with data about functions of sleep in
the regulation of dendritic spines, memory, and the immune system,
given the already existing evidence that these structures and pro-
cesses involve protein fragments. Extracellular and intracellular
fragments, possibly hundreds of them, produced at low but physi-
ologically significant levels, are conjectured to be a problem for
systems that comprise fragment-generating proteases and fragment-
destroying proteasomal pathways (36). The emergence of sleep as a
solution of this problem, and proposed mechanistic features of that
solution might account for the inability of natural selection to
strongly shorten or eliminate sleep during evolution, despite fitness
costs of sleep. Specific properties of extant sleep, including its dif-
ferent kinds, its intricate regulation, and its roles in memory, im-
munity, and other aspects of modern organisms may be adaptations
that emerged since the early setting of a simpler primordial sleep. In
sum, the FG hypothesis suggests a verifiable, molecular, and pos-
sibly chief reason because of which sleep evolved in the first place.
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